arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

CareDx, Inc.

CDNA
$76.34 ▼ -9.50 (-11.07%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
57 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
31
Health
Poor
Bearish
auto_awesome

Analytical Summary

CareDx, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $4.0B
Dividend Yield —
Revenue Growth 39.3% ↘
Op. Margin 5.8% ↘
ROIC 3.1% ↘
FCF / Share $0.21 ↘
Trailing P/E 206.3x
Price / Book 8.6x
FCF Yield 0.3%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

57-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$139.36M
↑ +39.3% —
Net Income Profit after all expenses
$2.81M
— 0.0% —
Operating Margin Operating profit as % of sales
5.8%
↓ -93.2% 17th
FCF / Share Free cash flow per share
$0.21
↓ -61.9% —
Long-Term Debt Long-term obligations
$0.00
— —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑
34
Returns ↓
37
Cash Quality
7

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 15 years · 57 quarters